DAC Beachcroft Advises on Reverse Takeover of Premaitha Health
DAC Beachcroft has advised Panmure Gordon and Cairn Financial Partners on the £10.5 million reverse takeover of leading DNA analysis company, Premaitha Health, by global investment group, ViaLogy.
Under the terms of the deal, Premaitha was readmitted to AIM on 4 July and raised £7.2 million through a successful placing.